4tsy
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==Crystal structure of FraC with lipids== | ==Crystal structure of FraC with lipids== | ||
- | <StructureSection load='4tsy' size='340' side='right' caption='[[4tsy]], [[Resolution|resolution]] 3.14Å' scene=''> | + | <StructureSection load='4tsy' size='340' side='right'caption='[[4tsy]], [[Resolution|resolution]] 3.14Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4tsy]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TSY OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[4tsy]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Actinia_fragacea Actinia fragacea]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TSY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TSY FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=HTO:HEPTANE-1,2,3-TRIOL'>HTO</scene>, <scene name='pdbligand=HXJ:2-[[(E,2S,3R)-2-(HEXANOYLAMINO)-3-OXIDANYL-DEC-4-ENOXY]-OXIDANYL-PHOSPHORYL]OXYETHYL-TRIMETHYL-AZANIUM'>HXJ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.14Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=HTO:HEPTANE-1,2,3-TRIOL'>HTO</scene>, <scene name='pdbligand=HXJ:2-[[(E,2S,3R)-2-(HEXANOYLAMINO)-3-OXIDANYL-DEC-4-ENOXY]-OXIDANYL-PHOSPHORYL]OXYETHYL-TRIMETHYL-AZANIUM'>HXJ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tsy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tsy OCA], [https://pdbe.org/4tsy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tsy RCSB], [https://www.ebi.ac.uk/pdbsum/4tsy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tsy ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/ACTPC_ACTFR ACTPC_ACTFR] Pore-forming protein that forms cations-selective hydrophilic pores of around 1 nm and causes cardiac stimulation and hemolysis. Pore formation is a multi-step process that involves specific recognition of membrane sphingomyelin (but neither cholesterol nor phosphatidylcholine) using aromatic rich region and adjacent phosphocholine (POC) binding site, firm binding to the membrane (mainly driven by hydrophobic interactions) accompanied by the transfer of the N-terminal region to the lipid-water interface and finally pore formation after oligomerization of several monomers.<ref>PMID:19563820</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 4tsy" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4tsy" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Cytolysin 3D structures|Cytolysin 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Actinia fragacea]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Caaveiro JMM]] |
- | [[Category: | + | [[Category: Tanaka K]] |
- | [[Category: | + | [[Category: Tsumoto K]] |
- | + | ||
- | + | ||
- | + |
Current revision
Crystal structure of FraC with lipids
|